CureVac strikes COVID vaccine alliance with Bayer

German biotech firm CureVac has agreed an alliance with drugmaker Bayer to help it seek regulatory approval for its experimental COVID-19 vaccine and distribute doses, the two companies said on Thursday.

Ciara Lee reports